Method for monitoring COVID-19
OwnerDawn Bennettinventor
Life of this patent
Estimating the term…
Loading patent…
OwnerDawn Bennettinventor
Estimating the term…
A method of sampling and testing for SARS-COV-2 virus in nasal and nasopharyngeal fluid using a plurality of microfluidic channels with a plurality of integrated electrodes in the microfluidic channels to detect the virus. In one example embodiment, a plurality of antibodies are fixed on a surface of at least one electrode by positive dielectrophoresis that increases the sensitivity of detection. Viral antigens bind to the antibodies separating from the fluid thereby signally that the virus is present as evidenced by the detection of the antigens. Sampling by microfluidic channels is more comfortable to a patient because microfluidic channels are soft, flexible and narrow compared to swabs. Another example embodiment of a method using microfluidic channels for collecting tears or saliva to determine blood glucose levels using a smartphone that has been modified to incorporate external filters quantitate glucose levels is also described.
A microfluidic device for detecting a presence of SARS-CoV-2 virus, comprising:
A system for detecting a presence of SARS-CoV-2 virus in fluid, comprising:
A filtering microfluidic device for detecting a presence of SARS-CoV-2 virus, comprising:
Dependencies are inferred from the claim text.